European Journal of Cancer
Volume 37, Issue 3 , Pages 332-339 , February 2001

Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer

  • A de Graeff

      Affiliations

    • Department of Internal Medicine, F.02.126, University Medical Center, Heidelberglaan 100, 3584 HM Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-30-2506308; fax: +31-30-2523741
  • ,
  • J.R.J de Leeuw

      Affiliations

    • Research Group Psychology of Health and Illness, University Medical Center, Utrecht, The Netherlands
  • ,
  • W.J.G Ros

      Affiliations

    • Research Group Psychology of Health and Illness, University Medical Center, Utrecht, The Netherlands
  • ,
  • G.J Hordijk

      Affiliations

    • Department of Otorhinolaryngology, University Medical Center, Utrecht, The Netherlands
  • ,
  • G.H Blijham

      Affiliations

    • Department of Internal Medicine, F.02.126, University Medical Center, Heidelberglaan 100, 3584 HM Utrecht, The Netherlands
  • ,
  • J.A.M Winnubst

      Affiliations

    • Research Group Psychology of Health and Illness, University Medical Center, Utrecht, The Netherlands

Received 20 December 1999 ,Revised 18 October 2000 ,Accepted 27 October 2000.

References 

  1. Editorial . Quality of life and clinical trials. Lancet. 1995;346:1–2
  2. Moinpour CM. Measuring quality of life: an emerging science. Sem Oncol. 1994;21(Suppl. 10):48–63
  3. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 1994;12:608–616
  4. Karnofsky DA, Burchenal JH. The evaluation of chemotherapeutics in cancer. In:  Macleod CM editors. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949;p. 191–205
  5. Weeks J. Quality-of-life assessment, performance status upstaged?. J Clin Oncol. 1992;10:1827–1829
  6. Shipp MA, Harrington DP, Klatt MM. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med. 1986;104:757–764
  7. Sorensen JB, Badsberg JH. Prognostic factors in resected stage I and II adenocarcinoma of the lung. J Thorac Cardiovasc Surg. 1990;99:218–226
  8. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;40:2220–2224
  9. Buccherei GF, Ferrigno D, Tamburini , Brunelli C. The patients' perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer. 1995;12:45–58
  10. Ganz PA, Lee JJ, Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 1991;67:3131–3135
  11. Herndon JE, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma. Cancer. 1999;15:333–340
  12. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol. 1989;15:235–242
  13. Ruckdeschel JC, Piantadosi S. Quality of life assessment in lung surgery for bronchogenic carcinoma. Theoretical Surg. 1990;6:201–205
  14. Ruckdeschel JC, Piantadosi S. Quality of life in lung cancer surgical adjuvant trials. Chest. 1994;106(Suppl. 6):3245–3255
  15. Coates A, Gebski V, Signorini D, et al.  for the Australian New Zealand Breast Cancer Trials Group. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol. 1992;10:1833–1838
  16. Seidman AD, Portenoy R, Yao TJ, et al.  Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Institute. 1995;87:1316–1322
  17. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol. 1996;14:171–175
  18. Sloan JA, Loprinzi CL, Kuross SA. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–3673
  19. Wisloff F, Hjorth M. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol. 1997;97:29–37
  20. Coates A, Thomson T, McLeod GR, et al.  Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer. 1993;29A:1731–1734
  21. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?. Br J Cancer. 1990;62:695–699
  22. Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK. Quality of life and survival: the role of multidimensional symptom assessment. Cancer. 1998;83:173–179
  23. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997;33:1025–1030
  24. Dancey J, Zee B, Osoba D, et al.  Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy. Qual Lif Res. 1997;6:151–158
  25. Loprinzi CL, Laurie JA, Wieand HS, et al.  for the North Central Cancer Treatment Group. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol. 1994;12:601–607
  26. Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG. Quality of life of cancer patients with different prognoses. Qual Life Research. 1994;3:143–154
  27. Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdal K. Prognostic factors and survival in a heterogenous sample of cancer patients. Br J Cancer. 1996;73:1594–1599
  28. Spitzer WO, Dobson AJ, Hall J, et al.  Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis. 1981;14:559–585
  29. Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987;258:3125–3130
  30. Mackillop WJ, Zhang-Solomons J, Groome PA, Paszat L, Holowaly E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol. 1997;15:1680–1689
  31. Kogenivas K, Marmot MG, Fox AJ, Goldblatt PO. Socioecomomic differences in cancer survival. J Epidemiol Community Health. 1991;45:216–219
  32. De Boer MF, Sanderson RJ, Schmitz PIM, Knegt PP. Medical correlates of head and neck cancer relapse and survival: a review of the literature. In de Boor MF, ed. Physical and Psychosocial Correlates of Rehabilitation, Survival and Relapse in Head and Neck Cancer Patients. Eburon Publishers, 1998, 69–99.
  33. Aaronson NK, Ahmedzai S, Bergman B, et al.  The European Organization for Research and Treatment of Cancer QLQ-C30; A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  34. Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer. Acta Oncologica. 1992;31:311–321
  35. Bjordal K, Ahlner-Elmqvist M, Tolleson E, et al.  on behalf of the EORTC Quality of Life Study Group. Development of a European for Research and Treatment of cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer. Acta Oncol. 1994;33:879–885
  36. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al.  for the European Organization for Research and Treatment of Cancer Quality of Life Study Group. Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17:1008–1019
  37. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold M on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 Scoring Manual, 2nd edn. Brussels, EORTC, 1997.
  38. Radloff LS. The CES-D Scale: a self-report depression scale for research in a general population. Appl Psychol Measurement. 1977;1:385–401
  39. Hanewald GJFP. CES-D: de Nederlandse Versie. Een Onderzoek naar de Betrouwbaarheid en de Validiteit. Amsterdam: Vakgroep Klinische Psychologie, Universiteit van Amsterdam; 1992;
  40. Norusis MJ. SPSS for Windows. Chicago: SPSS Inc; 1993;
  41. Centraal Bureau voor de Statistiek . Standaard Beroepenclassificatie 1992. Den Haag, The Netherlands: SDU Publishers; 1993;
  42. American Joint Committee on Cancer . AJCC Cancer Staging Manual 9. 5th edn.. Philadelphia: Lippincott Raven; 1997;
  43. De Boer MF, van den Borne B, Pruyn JFA, et al.  Psychosocial and physical correlates of survival and recurrence in patients with head and neck cancer. Cancer. 1998;83:2567–2579
  44. Hislop TG, Waxler NE, Coldman AJ, Elwood JM, Kan L. The prognostic significance of psychosocial factors in women with breast cancer. J Chron Dis. 1987;40:729–735
  45. Deleyannis FWB, Thomas TB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst. 1996;88:542–549
  46. Bem-Schlomo Y, Smith GD, Shipley M, Marmot MG. Magnitude and causes of mortality differences between married and unmarried men. J Epidemiol Community Health. 1993;47:200–205
  47. Joung IMA, van de Mheen H, Stronks K, van Poppel FWA. Mackenbach. Differences in self-reported morbidity by marital status and by living arrangement. Int J Epidemiol. 1994;23:91–97
  48. Joung IMA, Glerum JJ, van Poppel FWA, Kardaun JWPF, Mackenbach JP. The contribution of specific causes of death to mortality differences by marital status in the Netherlands. Eur J Public Health. 1996;6:142–149
  49. Blanchard CG, Albrecht T, Ruckdeschel J, Grant CH, Malcolm Hemmick R. The role of social support in adaptation to cancer and survival. J Psychosocial Oncol. 1995;13:75–95
  50. Creagan ET. Attitude and disposition: do they make a difference in cancer survival?. Mayo Clin Proc. 1997;72:160–164

PII: S0959-8049(00)00385-3

European Journal of Cancer
Volume 37, Issue 3 , Pages 332-339 , February 2001